Skip to main content
Premium Trial:

Request an Annual Quote

Lynx to Provide Gene Expression Services for NIH Database

NEW YORK, Feb. 26 (GenomeWeb News) - Lynx Therapeutics will provide gene expression analysis services worth several million dollars to NIH to build a mouse reference transcriptome database, the company said today.


Under the agreement, with SAIC-Frederick on behalf of a consortium of NIH institutes, Lynx will use its Massively Parallel Signature Sequencing technology to study gene expression patterns in mouse tissue samples provided by NIH. The data will enter a reference transcriptome database.


Lynx, SAIC-Frederick, and a number of NIH institutes already collaborate on several genome structure and gene expression projects, according to the company.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.